secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001356576-25-000042
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus stockholders elect directors, approve say-on-pay and KPMG ratification
-------------------------------------------------------------------------------

- Carolee Barlow and Jack Khattar re-elected as Class I directors; ~46.1M and ~46.5M votes for, respectively.
- Non-binding advisory vote on executive compensation approved: ~45.8M for, ~1.7M against.
- Ratification of KPMG as independent auditor for FY2025 passed: ~49.2M for, ~0.3M against.
- Record date April 22, 2025; 55,989,623 shares outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000042/0001356576-25-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000042/supn-20250616.htm
  HTML page:      https://secwatch.observer/filing/0001356576-25-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer